Last reviewed · How we verify

NCT04731415

Physiologic Change of Posterior Ocular Segment During Pregnancy

Not yet recruiting NA Last updated 30 June 2021
What this trial tests

NA trial testing Optical coherence tomography and optical coherence tomography angiography (Optovue®) in Retinal Vascular in 69 participants. Not yet recruiting.

Timeline
1 July 2021
Primary endpoint
30 December 2025
30 June 2026

Quick facts

Lead sponsorKhon Kaen University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment69
Start date1 July 2021
Primary completion30 December 2025
Estimated completion30 June 2026
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Khon Kaen University

Who can join

18 and older, female only, with Retinal Vascular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Women's physiology changes markedly during normal pregnancy. The most distinct alterations occur in the hormonal and cardiovascular systems. There is a dramatic increase in both estrogen and progesterone. Blood volume starts to increase in the first gestational period and reaches a peak in the third trimester. The physiologic ocular changes during pregnancy are mainly the result of hormonal and blood volume increase, and then are usually marked in the third trimester.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Khon Kaen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04731415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing